Zoetis ZTS
NYSE ZTS
$75.48 -1.20 (-1.56%)
At close: Aug 20, 2026 · 1:47 PM UTC

Zoetis (ZTS) EBT Margin (2012 - 2026)

Zoetis (ZTS) posted quarterly EBT Margin of 33.51% for Q1 2026, down 166.0% year-over-year from 50.77% in Q1 2025, and up 5.11% quarter-over-quarter from 31.88% in Q4 2025.

Zoetis (ZTS) EBT Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported EBT Margin for 15 consecutive years, with 33.51% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin fell 166.0% year-over-year to 33.51%; the TTM figure through Mar 2026 stood at 34.79% (up 69.0% YoY), while the FY2025 annual figure was 35.49%, up 164.0% from the prior year.
  • EBT Margin advanced to 33.51% in Q1 2026 per ZTS's latest filing, from 31.88% in the prior quarter.
  • Across five years, EBT Margin topped out at 40.0% in Q2 2023 and bottomed at 29.02% in Q4 2022.
  • Historically, EBT Margin has averaged 34.04% across 5 years, with a median of 33.51% in 2026.
  • Annual changes were most pronounced in 2023 — EBT Margin surged 735 bps — and 2024, when it tumbled 696 bps.
  • Zoetis' EBT Margin stood at 29.02% in 2022, then rose by 1 bps to 29.37% in 2023, then advanced by 8 bps to 31.59% in 2024, then increased by 1 bps to 31.88% in 2025, then increased by 5 bps to 33.51% in 2026.
  • Business Quant data shows ZTS's EBT Margin at 33.51% in Q1 2026, 31.88% in Q4 2025, and 36.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn -10.99%
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 13.34%
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn 47.58%
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn -1.70%
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 16.91%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 4.09%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn -0.38%

Historic Data

Download Data
DateValue
Jun 30, 2026 35.09%
Mar 31, 2026 33.51%
Dec 31, 2025 31.88%
Sep 30, 2025 36.96%
Jun 30, 2025 36.67%
Mar 31, 2025 35.17%
Dec 31, 2024 31.59%
Sep 30, 2024 36.60%
Jun 30, 2024 33.04%
Mar 31, 2024 34.11%
Dec 31, 2023 29.37%
Sep 30, 2023 33.33%
Jun 30, 2023 40.00%
Mar 31, 2023 34.85%
Dec 31, 2022 29.02%
Sep 30, 2022 33.32%
Jun 30, 2022 32.65%
Mar 31, 2022 36.61%
Dec 31, 2021 25.72%
Sep 30, 2021 33.12%